Author

A. P. Sharda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

A. M. Intlekofer· 1 shared A. N. Lane· 1 shared B. H. Segal· 1 shared C. M. James· 1 shared E. A. Repasky· 1 shared G. A. Holling· 1 shared G. Qiao· 1 shared K. H. Eng· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. M. Intlekofer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintMay 7, 2021

ARS2-directed alternative splicing mediates CD28 driven T cell glycolysis and effector function

G. A. Holling, A. P. Sharda, M. M. Honikel…·S. H. Olejniczak

This study shows ARS2 promotes CD28-driven T cell glycolysis and effector function through alternative splicing of Pkm2, enhancing anti-tumor immunity.

DOI 10.1101/2021.05.07.442963

humanbulk RNA-seq

𝕏 PostBluesky